Arca
Skip to content

Knee arthroplasty

Drug research and approvals for knee arthroplasty: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 16, 2026, 292 studies of knee arthroplasty are recruiting on ClinicalTrials.gov, and Health Canada has authorized 13 drug trials for it since 2013.

  • Recruiting worldwide: 292
  • Trials authorized in Canada: 13
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting Now

Newest start dates first, of 292 recruiting on ClinicalTrials.gov ↗

Trials Authorized in Canada

The 10 newest of 13; search them all in Canada trials
Dec 19, 2025A phase 3, multicenter, double-blinded, randomized study to evaluate regn7508, a factor xi monoclonal antibody, versus acetylsalicylic acid for prophylaxis of…REGN7508 / ACETYLSALICYLIC ACIDRegeneronPending
May 7, 2024The impact of additional post-operative doses of tranexamic acid on pain, mobility and bleeding following total hip and total knee arthroplasty: a randomized…TRANEXAMIC ACIDST MARY¿S RESEARCH CENTREOngoing
Feb 10, 2023Randomized, controlled trial comparing the effectiveness of sedation-epidural anesthesia to spinal anasthesia in outpatient hip or knee arthroplastyCHLOROPROCAINECIUSSS DE L'EST DE L'ILE-DE-MONTRÉALClosed
Dec 2, 2022A phase 2, multicenter, randomized, open-label, active-control study of regn9933, a factor xi monoclonal antibody, for prevention of venous thromboembolism…REGN9933RegeneronOngoing
Jun 21, 2022Topical vancomycin for infection prophylaxis in total hip and knee arthroplastyVANCOMYCINGOVERNORS OF THE UNIVERSITY OF CALGARYPending
May 11, 2022A phase 2b, randomized, double blind, placebo and active comparator, multicenter, safety, and efficacy trial of atx 101 in subjects undergoing total knee…BUPIVACAINE (ATX-101) / CELECOXIBALLAY THERAPEUTICS, INCClosed
Nov 22, 2019Protocol title: extended venous thromboembolism prophylaxis comparing rivaroxaban and aspirin to aspirin following total hip and knee arthroplasty epcat iiiACETYLSALICYLIC ACIDDR SUDEEP SHIVAKUMAROngoing
Apr 9, 2019Opioid sparing analgesic strategies for enhanced recovery after total knee arthroplastyKETAMINEDR VINCENT CHANOngoing
Aug 8, 2017A randomized, double-blind, double-dummy, multicenter, adaptive design, dose-escalation (part 1) and dose-response (part 2) study to evaluate the safety and…JNJ-64179375 / APIXABANJohnson & JohnsonOngoing
Nov 26, 2015A phase 3, multi-center, long-term observational study of subjects from tanezumab studies who undergo a total knee, hip, or shoulder replacementPF-04383119 (TANEZUMAB)PfizerOngoing

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.